首页> 美国卫生研究院文献>HPB Surgery >Is There a Role for Perioperative Nutritional Support in Liver Resection?
【2h】

Is There a Role for Perioperative Nutritional Support in Liver Resection?

机译:肝切除术中围手术期的营养支持有作用吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Resection of hepatocellular carcinoma is associated with high rates of morbidity and mortality. Since intensive nutritional support can reduce the catabolic response and improve protein synthesis and liver regeneration, we performed a prospective study to investigate whether perioperative nutritional support could improve outcome in patients undergoing hepatectomy for hepatocellular carcinoma.Methods: We studied 124 patients undergoing resection of hepatocellular carcinoma. Sixty-four patients (39 with cirrhosis, 18 with chronic active hepatitis, and 7 with no associated liver disease) were randomly assigned to receive perioperative intravenous nutritional support in addition to their oral diet, and 60 patients (33 with cirrhosis, 12 with chronic active hepatitis, and 15 with no associated liver disease) were randomly assigned to a control group. The perioperative nutritional therapy consisted of a solution enriched with 35 percent branched chain amino acids, dextrose, and lipid emulsion (50 percent medium-chain trigylcerides) given intravenously for 14 days perioperatively).Results: There was a reduction in the overall postoperative morbidity rate in the perioperative-nutrition group as compared with the control group (34 percent vs. 55 percent; relative risk, 0.66; 95 percent confidence interval, 0.45 to 0.96), predominantly because of fewer septic complications (17 percent vs. 37 percent; relative risk, 0.57; 95 percent confidence interval, 0.34 to 0.96). There were also a reduction in the requirement for diuretic agents to control ascites (25 percent vs. 50 percent; relative risk, 0.57; 95 percent confidence interval, 0.37 to 0.87), less weight loss after hepatectomy (median loss, 0 kg vs. 1.4 kg; P=0.01), and less deterioration of liver function as measured by the change in the rate of clearance of indocyanine green (–2.8 percent vs. –4.8 percent at 20 minutes, P=0.05). These benefits were seen predominantly in the patients with underlying cirrhosis who underwent major hepatechtomy. There were five deaths during hospitalization in the perioperativenutrition group, and nine in the control group (P not significant).Conclusions: Perioperative nutritional support can reduce complications after major hepatectomy for hepatocellular carcinoma associated with cirrhosis.
机译:背景:肝细胞癌的切除与高发病率和高死亡率相关。由于强化营养支持可以减少分解代谢反应并改善蛋白质合成和肝脏再生,因此我们进行了一项前瞻性研究,以研究围手术期营养支持是否可以改善肝癌肝切除术患者的预后。方法:我们研究了124例肝癌切除术患者。 。除口服饮食外,随机分配了64例患者(肝硬化39例,慢性活动性肝炎18例,无相关肝病7例)接受围手术期静脉营养支持,60例患者(33例肝硬化,12例慢性肝炎)。活动性肝炎和15例无相关肝病的患者)随机分为对照组。围手术期营养治疗由围手术期静脉注射14天的富含35%支链氨基酸,葡萄糖和脂质乳剂(50%中链甘油三酸酯)的溶液组成。围手术期营养组与对照组相比(34%比55%;相对危险度为0.66; 95%置信区间为0.45至0.96),主要是因为脓毒症并发症较少(17%比37%;相对风险为0.57; 95%的置信区间为0.34至0.96)。利尿剂控制腹水的需求也减少了(25%比50%;相对风险为0.57; 95%置信区间为0.37至0.87),肝切除术后的体重减轻更少(中位数损失为0 kg vs. 0 kg。 1.4千克; P = 0.01),并且通过吲哚菁绿清除率的变化测得的肝功能恶化较少(20分钟时–2.8%对–4.8%,P = 0.05)。这些益处主要发生在接受大肝切除术的潜在肝硬化患者中。围手术期营养组住院期间死亡5例,对照组死亡9例(P不显着)。结论:围手术期营养支持可以减少因肝硬化合并肝细胞癌而进行大肝切除术后的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号